Cargando…
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study
BACKGROUND: Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have been reported since December 2019. We aim to explore risk factors associated with mortality in COVID-19 patients and assess the use of D-dimer as a biomarker for disease severity and clinical outcome. METHODS: We retrospectiv...
Autores principales: | Yao, Yumeng, Cao, Jiatian, Wang, Qingqing, Shi, Qingfeng, Liu, Kai, Luo, Zhe, Chen, Xiang, Chen, Sisi, Yu, Kaihuan, Huang, Zheyong, Hu, Bijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348129/ https://www.ncbi.nlm.nih.gov/pubmed/32665858 http://dx.doi.org/10.1186/s40560-020-00466-z |
Ejemplares similares
-
Low CD4 T cell count predicts radiological progression in severe and critically ill COVID-19 patients: a case control study
por: Wang, Qingqing, et al.
Publicado: (2021) -
Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020) -
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020) -
Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
por: Cao, Jiatian, et al.
Publicado: (2020) -
Predictors of mortality for hospitalized young adults aged less than 60 years old with severe COVID-19: a retrospective study
por: Liu, Zilong, et al.
Publicado: (2021)